Endocrine Health in LGBTQ+ Populations

Endocrine health in LGBTQ+ populations encompasses the unique healthcare needs and disparities faced by individuals who identify as lesbian, gay, bisexual, transgender, queer, or other sexual and gender minorities. Hormonal transitions associated with gender-affirming care, including hormone therapy and surgical interventions, require specialized management tailored to individual preferences and goals. Access to affirming and culturally competent healthcare services is essential for addressing hormone-related concerns and promoting endocrine health in LGBTQ+ communities. Moreover, awareness of the impact of societal stigma, discrimination, and minority stress on endocrine health underscores the importance of holistic approaches to care that address social determinants of health and promote health equity for LGBTQ+ individuals.

    Related Conference of Endocrine Health in LGBTQ+ Populations

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Endocrine Health in LGBTQ+ Populations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in